Trading in newly issued shares and warrants in Diamyd Medical starts on June 29, 2017

Trading of newly issued shares and warrants in Diamyd Medical as a result of the completed rights issue will commence on June 29, 2017. Following registration of the rights issue, including issued units to underwriters and financial advisor, Diamyd Medical's share capital will amount to a total of 5,713,545.15 SEK , where of 2,130,186 Series A shares and 54,203,718 Series B shares, each share with a quota value of (rounded) 0.1014 SEK. About Diamyd MedicalDiamyd Medical is dedicated to finding a cure for diabetes and other serious inflammatory diseases through pharmaceutical